Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lab, Imaging Industries Fear Super Committee Cuts

This article was originally published in The Gray Sheet

Executive Summary

Clinical laboratory and imaging industry groups fear that their industries could take a hit during the deficit-reducing “super committee” meetings scheduled for this November.

You may also be interested in...



In Kerry’s Departure From Senate, Device Industry Will Lose A Well-Positioned Friend

Sen. John Kerry, D-Mass., has been a strong advocate for the medical imaging and device industries. His expected departure to become secretary of state could leave a hole on the critical Senate Finance Committee.

In Deficit Reduction, Medicare Cost-Shifting Is Not The Way To Go – Panel

Congress needs to consider the health care system as a whole and not just one-off Medicare cuts as it works to reduce the deficit, health policy leaders stressed during an Oct. 11 panel discussion in Washington, D.C.

In Deficit Reduction, Medicare Cost-Shifting Is Not The Way To Go – Panel

Congress needs to consider the health care system as a whole and not just one-off Medicare cuts as it works to reduce the deficit, health policy leaders stressed during an Oct. 11 panel discussion in Washington, D.C.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT030461

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel